209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension

Eric Morand; Joan T Merrill; David A Isenberg; Amy H Kao; Cristina Vazquez-Mateo; Stephen Wax; Peter Chang; Kishore Pudota; Cynthia Aranow; Daniel J Wallace

doi:10.1136/lupus-2019-lsm.209

Article info

Abstracts

209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension

Free

Authors

Eric Morand 1Monash University, Melbourne, Australia PubMed articles Google scholar articles
Joan T Merrill 2Oklahoma Medical Research Foundation PubMed articles Google scholar articles
David A Isenberg 3University College London, London, UK PubMed articles Google scholar articles
Amy H Kao 4EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, USA PubMed articles Google scholar articles
Cristina Vazquez-Mateo 4EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, USA PubMed articles Google scholar articles
Stephen Wax 4EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, USA PubMed articles Google scholar articles
Peter Chang 4EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, USA PubMed articles Google scholar articles
Kishore Pudota 4EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, USA PubMed articles Google scholar articles
Cynthia Aranow 5Feinstein Institute for Medical Research PubMed articles Google scholar articles
Daniel J Wallace 6Cedars-Sinai Medical Center, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA PubMed articles Google scholar articles

Citation

Morand E, T Merrill J, A Isenberg D, et al

Lupus Science & Medicine 2019;6:doi: 10.1136/lupus-2019-lsm.209

Publication history

First published April 5, 2019.

Online issue publication

May 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password